tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR

Paradigm Biopharmaceuticals (PAR) Revenue

Compare
39 Followers

Paradigm Biopharmaceuticals Revenue

Paradigm Biopharmaceuticals had a revenue of 35.42K in the quarter ending Jun 30, 2025, with 112.10%. This bring the company's revenue in the last twelve months to 52.12K, Increased -36.82%. In the fiscal year ending Dec 31, 2025, Paradigm Biopharmaceuticals had annual revenue of 52.12K with -20.79% growth.
Revenue (ttm)
52.12K
Revenue Growth
-20.79%
P/S Ratio
2795.41
Revenue/Employee
Employees
Market Cap
$145.70M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
52.12K-13.68K+79.21%
Dec 31, 2024
65.80K19.04K+140.72%
Dec 31, 2023
46.76K-32.46K+59.02%
Dec 31, 2022
79.22K58.67K+385.54%
Dec 31, 2021
20.55K-2,055,000.00%
Dec 31, 2020
-2.98M
Dec 31, 2019
2.98M301.50K+111.24%
Dec 31, 2018
2.68M859.20K+147.12%
Dec 31, 2017
1.82M532.71K+141.28%
Dec 31, 2016
1.29M